Cargando…
Circulating Cell-Free Mitochondrial DNA: A Potential Blood-Based Biomarker for Sarcopenia in Patients Undergoing Maintenance Hemodialysis
BACKGROUND: Mitochondrial impairment and exaggerated inflammation are hallmarks of sarcopenia. Recently, cell-free mitochondrial DNA (cf-mtDNA) has been in the spotlight as an endogenous danger molecule that can potentially elicit inflammation. Yet, its actual impact on sarcopenia, especially in pat...
Autores principales: | Fan, Zhen, Guo, Yi, Zhong, Xiao-yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919682/ https://www.ncbi.nlm.nih.gov/pubmed/35263317 http://dx.doi.org/10.12659/MSM.934679 |
Ejemplares similares
-
Increased level of free‐circulating MtDNA in maintenance hemodialysis patients: Possible role in systemic inflammation
por: Zhong, Xiao‐Yi, et al.
Publicado: (2022) -
Development of a Practical Screening Tool to Predict Sarcopenia in Patients on Maintenance Hemodialysis
por: Du, Xiaoju, et al.
Publicado: (2022) -
Sarcopenia and echocardiographic parameters for prediction of cardiovascular events and mortality in patients undergoing maintenance hemodialysis
por: Zhang, Mengyan, et al.
Publicado: (2022) -
Nutritional Status Association With Sarcopenia in Patients Undergoing Maintenance Hemodialysis Assessed by Nutritional Risk Index
por: Kurajoh, Masafumi, et al.
Publicado: (2022) -
The triglyceride-glucose index as a novel marker associated with sarcopenia in non-diabetic patients on maintenance hemodialysis
por: Chen, Ruoxin, et al.
Publicado: (2022)